The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.00
Bid: 134.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.493%)
Open: 135.00
High: 135.00
Low: 135.00
Prev. Close: 135.00
ECEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Sep 2017 07:00

RNS Number : 8986P
Eurocell plc
06 September 2017
 

6 September 2017

 

Eurocell PLC

 

Director/PDMR Shareholding

 

Eurocell plc (LSE: ECEL), the market leading, vertically integrated UK manufacturer, distributor and recycler of innovative window, door and roofline PVC products, announces that on 5 September 2017, Chief Executive Mark Kelly acquired 123,864 shares at nil cost under the Company Deferred Share Plan and sold 58,534 shares at 235.00p to satisfy the related tax liabilities. Mark Kelly's holding in the company, following these transactions, is 109,469 shares.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Mark Kelly

2.

Reason for the notification

a)

Position / status

Chief Executive

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell PLC

b)

Legal Entity Identifier

213800RH62IQ7S9OFQ55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.001 each

 

ISIN number GB00BVV2KN49

b)

Nature of the transaction

Purchase of ordinary shares under the Company Deferred Share Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

nil

123,864

 

 

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

N/A - single transaction

e)

Date of the transaction

5 September 2017 (UK)

f)

Place of the transaction

Outside a trading venue

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Mark Kelly

2.

Reason for the notification

a)

Position / status

Chief Executive

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell PLC

b)

Legal Entity Identifier

213800RH62IQ7S9OFQ55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.001 each

 

ISIN number GB00BVV2KN49

b)

Nature of the transaction

Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

235.00p

58,334

 

 

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 N/A - single transaction

e)

Date of the transaction

5 September 2017 (UK)

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

For further information:

 

Eurocell PLC

Tel: 01773 842 100

Gerald Copley

Company Secretary

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUGUWUBUPMGQA
Date   Source Headline
7th Apr 20163:58 pmRNSConfirmation of CEO Board Change
16th Mar 20167:00 amRNS2015 Full Year Results
9th Mar 20167:00 amRNSAcquisition
26th Jan 20167:04 amRNSDirectorate Change
21st Jan 20167:00 amRNSTrading Statement
1st Dec 20153:06 pmRNSHolding(s) in Company
11th Nov 201510:56 amRNSDirector Declaration
18th Sep 20159:56 amRNSHolding(s) in Company
17th Sep 201511:31 amRNSHolding(s) in Company
17th Sep 201511:29 amRNSHolding(s) in Company
15th Sep 201511:06 amRNSResult of Placing
15th Sep 20157:00 amRNSProposed Placing
25th Aug 20157:00 amRNSHalf Yearly Results
29th May 20152:59 pmRNSChange of Adviser
13th May 20155:32 pmRNSHolding(s) in Company
14th Apr 20157:00 amRNSAppointment of Joint Corporate Brokers
11th Mar 20154:33 pmRNSHolding(s) in Company
11th Mar 20153:17 pmRNSHolding(s) in Company
10th Mar 20157:03 amRNSAnnouncement of Grant Awards
9th Mar 20158:00 amRNSAdmission to Trading on London Stock Exchange
4th Mar 20152:31 pmRNSPublication of Prospectus
4th Mar 20157:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.